Learning from TIL to develop next generation cell therapies

Поділитися
Вставка
  • Опубліковано 8 вер 2024
  • Johm Haanen, head of Cancer Immunotherapy The Netherlands Cancer Institute, summarizes his talk at the First VHIO BBVA Foundation Symposium.

КОМЕНТАРІ •